

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares


Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection


Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers


UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted


DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares


(Sharecast News) - Oxford Biodynamics revealed on Wednesday that interim chairman Stephen Diggle had purchased 18,309 ordinary shares in the AIM-liste...


Oxford BioDynamics Annual Loss Widens On Increased Costs


Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient